Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder

Authors

Richard B. Lipton (ORCID: https://orcid.org/0000-0003-2652-2897)
Joshua M. Cohen (ORCID: https://orcid.org/0000-0002-0845-5160)
Lex Denysenko (ORCID: https://orcid.org/0000-0003-1605-4559)
Zipi Roth-Ben Arie
Verena Ramirez Campos
Dimos D. Mitsikostas (ORCID: https://orcid.org/0000-0002-4691-3388)
Cristina Tassorelli
Maja Galić

Institutions

Albert Einstein College of Medicine (US)
National and Kapodistrian University of Athens (GR)
University of Pavia (IT)
Thomas Jefferson University Hospital (US)
Teva Pharmaceuticals (Israel) (IL)
Laboratório Edol (Portugal) (PT)
Teva Pharmaceuticals (United States) (US)
Eginition Hospital (GR)

Publication Details

Journal: JAMA Neurology
Published: 2025-05-05
DOI: https://doi.org/10.1001/jamaneurol.2025.0806
Citations: 15
Primary Topic: Migraine and Headache Studies
Type: article
Field-Weighted Citation Impact: 22.07

Funders

Amgen
Eli Lilly and Company
Pfizer
Teva Pharmaceutical Industries
H. Lundbeck A/S

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder

Richard B. Lipton, Joshua M. Cohen, Lex Denysenko, Zipi Roth-Ben Arie et al.

May 5, 2025

15 citations

JAMA Neurology

Migraine and Headache Studies

22.07

article

Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder

Richard B. Lipton, Joshua M. Cohen, Lex Denysenko, Zipi Roth-Ben Arie, Verena Ramirez Campos, Dimos D. Mitsikostas, Cristina Tassorelli, Maja Galić

May 5, 2025article en

15 citations

Abstract

No abstract available for this paper.

JAMA NeurologyVol. 82(6)

Albert Einstein College of Medicine (US), National and Kapodistrian University of Athens (GR), University of Pavia (IT), Thomas Jefferson University Hospital (US), Teva Pharmaceuticals (Israel) (IL), Laboratório Edol (Portugal) (PT), Teva Pharmaceuticals (United States) (US), Eginition Hospital (GR)

Amgen, Eli Lilly and Company, Pfizer, Teva Pharmaceutical Industries, H. Lundbeck A/S

Good health and well-being

Openalex Percentile: Top 0%

Migraine and Headache Studies

22.07

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder — Richard B. Lipton, Joshua M. Cohen, et al. · JAMA Neurology (2025) | TGRS Research Map | TGRS